The effect of Qishengubiao Granule in asymptomatic patients with Omicron infection: A randomized control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006009

Enrollment

Unknown

Registered

2022-05-15

Start date

2022-05-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asymptomatic Omicron patients

Interventions

study group:qishengubiaokeli

control group:observation

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Asymptomatic patients with Omicron infection admitted in Shanghai Lingang Cabin Hospital

Exclusion criteria

Exclusion criteria: 1. Age <14 years old; 2. Pregnant women

Design outcomes

Primary

Measure	Time frame
Average time when nucleic acid turn negative;	—

Secondary

Measure	Time frame
Average hospital stay;Symptom exacerbation rate;	—

Countries

China

Contacts

Public ContactYiyang Zhan

yiyangzhan@sina.com18912972893

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026